Published 07-24-24
Submitted by Jazz Pharmaceuticals
Originally published by Jazz Pharmaceuticals
In celebration of Pride Month, we were joined by Celia Sandhya Daniels (she/they) who led an insightful discussion aimed at educating, raising awareness and calling for understanding and allyship by shedding light on her lived experiences and the challenges she’s faced as a trans woman living in India and the U.S.
We believe in creating a welcoming and inclusive society for all members of the LGBTQ+ community, and we appreciate Celia's courage in sharing her personal journey and highlighting the importance of transformative allyship.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. Please visit www.jazzpharmaceuticals.com for more information.
More from Jazz Pharmaceuticals